首页 | 本学科首页   官方微博 | 高级检索  
     


Involvement of PI3K/Akt pathway in prostate cancer--potential strategies for developing targeted therapies
Authors:Pommery Nicole  Hénichart Jean-Pierre
Affiliation:Institut de Chimie Pharmaceutique Albert Lespagnol, Université de Lille 2, Lille, France. henicha@pharma.univ-lille2.fr
Abstract:This review presents some therapeutic interventions actually considered in prostate cancer therapy to compensate constitutive activation of the PI3K/Akt signalling pathway induced, particularly, by mutations of PTEN gene. Special emphasis is placed on applicability of EGF-R tyrosine kinase, COX-2, PDK-1, mTOR and farnesyltransferase inhibitors.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号